PA
KRTX

Profund Advisors’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Profund Advisors’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6,895
Closed -$2.18M – 1206
2023
Q4 		$2.18M Sell
6,895
-1,039
-13% -$202K 0.09% 164
2023
Q3 		$1.34M Buy
7,934
+1,454
+22% +$273K 0.07% 221
2023
Q2 		$1.41M Sell
6,480
-1,056
-14% -$226K 0.08% 227
2023
Q1 		$1.37M Buy
+7,536
New +$1.44M 0.08% 204

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Profund Advisors's KRTX Position: Q1 2024 in Review

Profund Advisors sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 6,895 shares — an estimated $2.18M sold.

Profund Advisors first reported a position in KRTX in Q1 2023 and held it in 4 quarters. The position peaked at $2.18M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Profund Advisors reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Profund Advisors sold 6,895 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.18M.
  • Profund Advisors first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2023 and held it in 4 quarters.
  • Profund Advisors's Karuna Therapeutics, Inc. Common Stock position peaked at $2.18M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Profund Advisors's 13F filing for Q1 2024, filed 8 May 2024.